| 2020 | Detection of Targetable Genetic Alterations in Korean Lung Cancer Patients: A Comparison Study of Single-Gene Assays and Targeted Next-Generation Sequencing
| CANCER RESEARCH AND TREATMENT |
| 2020 | Expression of V-set immunoregulatory receptor in malignant mesothelioma | MODERN PATHOLOGY |
| 2019 | Unusual Case of Recurrent Pericardial Effusion - Erdheim-Chester Disease
| CIRCULATION JOURNAL |
| 2019 | Chronic Lymphocytic Myocarditis Confirmed by Electrogram-Guided Endomyocardial Biopsy | EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING |
| 2019 | Mutant Thr95Ile Transthyretin-Related Cardiac Amyloidosis With Polyneuropathy
| CIRCULATION JOURNAL |
| 2019 | Provisional Guideline Recommendation for EGFR Gene Mutation Testing in Liquid Samples of Lung Cancer Patients: A Proposal by the Korean Cardiopulmonary Pathology Study Group
| JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE |
| 2019 | Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function
| JOURNAL FOR IMMUNOTHERAPY OF CANCER |
| 2019 | Effect of thymectomy in elderly patients with non-thymomatous generalized myasthenia gravis | Journal of Neurology |
| 2019 | Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases | JOURNAL OF NEURO-ONCOLOGY |
| 2019 | Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer
| EMBO MOLECULAR MEDICINE |
| 2019 | Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation
| BMC PULMONARY MEDICINE |
| 2019 | Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lung | LUNG CANCER |
| 2019 | Dynamic changes in PD-L1 expression and CD8+ T cell infiltration in non-small cell lung cancer following chemoradiation therapy | LUNG CANCER |
| 2019 | Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer | Annals of Oncology |
| 2019 | Highly Multiplexed Fluorescence in Situ Hybridization for in Situ Genomics | Journal of Molecular Diagnostics |
| 2019 | Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice
| JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2019 | Indoor radon exposure increases tumor mutation burden in never-smoker patients with lung adenocarcinoma | LUNG CANCER |
| 2019 | Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non-small-cell Lung Cancer | CLINICAL LUNG CANCER |
| 2018 | Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation | LUNG CANCER |
| 2018 | Genetic and clinicopathologic characteristics of lung adenocarcinoma with tumor spread through air spaces | LUNG CANCER |
| 2018 | Malignant lymphoma arising in cardiac myxoma, presenting with peripheral arterial emboli | CARDIOVASCULAR PATHOLOGY |
| 2018 | Clinical characteristics of T790M-positive lung adenocarcinoma after resistance to epidermal growth factor receptor-tyrosine kinase inhibitors with an emphasis on brain metastasis and survival | LUNG CANCER |
| 2018 | Clinicopathologic analysis of 10 cases of pulmonary colloid adenocarcinoma and prognostic implication of invasive micropapillary component | PATHOLOGY RESEARCH AND PRACTICE |
| 2018 | Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors. | CANCER RESEARCH |
| 2017 | Validation of ALK/ROS1 Dual Break Apart FISH Probe probe in non-small-cell lung cancer | LUNG CANCER |
| 2017 | Biology of invasive mucinous adenocarcinoma of the lung.
| TRANSLATIONAL LUNG CANCER RESEARCH |
| 2017 | Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis
| ONCOTARGET |
| 2017 | Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement. | JOURNAL OF CLINICAL ONCOLOGY |
| 2017 | The frequency and clinical impact of HER2 alterations in lung adenocarcinoma
| PLOS ONE |
| 2017 | Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma | ANNALS OF ONCOLOGY |
| 2017 | Good Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests
| JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE |
| 2017 | Molecular Testing of Lung Cancers
| JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE |
| 2017 | PD-L1 expression and CD8+ tumor-infiltrating lymphocytes are associated with ALK rearrangement and clinicopathological features in inflammatory myofibroblastic tumors
| ONCOTARGET |
| 2017 | Concordance of programmed death-ligand 1 expression between primary and metastatic non-small cell lung cancer by immunohistochemistry and RNA in situ hybridization
| ONCOTARGET |
| 2016 | Transforming growth factor-beta 1 in humidifier disinfectant-associated children's interstitial lung disease | PEDIATRIC PULMONOLOGY |
| 2016 | Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative
| ONCOTARGET |
| 2016 | A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib | JOURNAL OF THORACIC ONCOLOGY |
| 2016 | Time, Dose, and Volume Responses in a Mouse Pulmonary Injury Model Following Ablative Irradiation | LUNG |
| 2016 | Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status. | LUNG CANCER |
| 2016 | MET Exon 14 Skipping in Non-Small Cell Lung Cancer. | ONCOLOGIST |
| 2016 | Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer.
| BMC CANCER |
| 2016 | A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806) | LUNG CANCER |
| 2016 | Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer. | TUMOR BIOLOGY |
| 2016 | A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2016 | An unusual cause of early aortic bioprosthetic valve failure | EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING |
| 2016 | Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
| JOURNAL OF TRANSLATIONAL MEDICINE |
| 2016 | Clinical course of stage IV invasive mucinous adenocarcinoma of the lung | LUNG CANCER |
| 2015 | LAMC2 enhances the metastatic potential of lung adenocarcinoma | CELL DEATH AND DIFFERENTIATION |
| 2015 | Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions
| RESPIRATORY RESEARCH |
| 2015 | Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer
| JOURNAL OF CARDIOTHORACIC SURGERY |
http://orcid.org/0000-0002-5718-3624
(Yonsei Health Research Network)
(8701798400)
